Eque-cel CAR-T Therapy

· Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eque-cel CAR-T Therapy, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis [Phase 2]